Developer docs
API playgroundTry for free, no card

Search company profiles

MIPS

Full company profile

uuid000va77

Namestring
MIPS
Legal namestring
MIPS
Websiteurl
mipscenter.com
Company typeenum
Private
Founded yearstring
-
Descriptiontext

MIPS is a semiconductor intellectual property (IP) company specializing in RISC-V processor architectures for physical AI applications at the autonomous edge. The company was acquired by GlobalFoundries (NASDAQ:GFS) in July 2024 and operates as a wholly-owned subsidiary, positioned within GlobalFoundries' vertically integrated physical AI platform that pairs processor IP with mature-node manufacturing. MIPS has completed a strategic pivot from its legacy MIPS instruction set architecture to RISC-V; its eighth-generation products are entirely RISC-V-based and focused on physical AI workloads in autonomous vehicles, robotics, and embedded edge computing. GlobalFoundries has further announced (January 2026) its acquisition of Synopsys' ARC Processor IP Solutions business to combine with MIPS, consolidating two established RISC architecture lineages under one parent.

MIPS's product portfolio includes the S8200 RISC-V neural processing unit (NPU) for AI inference at the edge, the P8700 six-core cluster scalable up to 64-way replication (768 threads) for high-performance processing, the I8500 multithreaded data movement processor, and the M8500 processor architecture for safety-certified microcontrollers. The company offers reference platforms including the MIPS Atlas Explorer simulation environment, a robotics control reference platform co-developed with Inova Semiconductors, and a Safety SDK with Green Hills Software targeting ASIL-D and SIL 3/4 certifications. Named design wins include Mobileye's EyeQ6 processor — powering 75% of the ADAS market across 1,200 vehicle models from 50 global OEMs — and ForwardEdge ASIC, a Lockheed Martin subsidiary, for mission-critical aerospace and defense applications.

MIPS operates as an IP licensing business, generating revenue through licensing fees and royalties paid by semiconductor companies and SoC designers who integrate MIPS RISC-V cores and NPUs into their own chip designs. Pricing is quote-based and negotiated per customer per project; no public pricing or standalone MIPS revenue is disclosed. Distribution is direct to enterprise customers, with go-to-market executed through industry events (RISC-V Summit, Chiplet Summit, Embedded World, GlobalFoundries Technology Summits), reference platforms co-developed with ecosystem partners (Arteris, Inova, Green Hills), and GlobalFoundries' manufacturing customer network. Note: a data conflict exists in the firmographics, which describe MIPS as a medical practice (Minimally Invasive Procedure Specialists in Highlands Ranch, CO) sharing the same name; this analysis is based on the predominant body of evidence describing the semiconductor IP company.

Short descriptiontext

MIPS, a GlobalFoundries subsidiary, licenses RISC-V processor IP cores and NPUs for physical AI applications in automotive ADAS, robotics, and embedded edge computing. Major design wins include Mobileye's EyeQ6 powering 75% of the ADAS market and ForwardEdge ASIC for defense.

Operating statusenum
Acquired
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersHighlands Ranch, United States
HQ citystring
Highlands Ranch
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
interventional radiology, vascular treatments, pelvic pain treatment, uterine fibroid embolization, minimally invasive procedures
Industry3 codes
PRIMARYHLAFABAK
Ambulatory Cardiology Diagnostic & Procedure Centers (Non-hospital-based)
Healthcare & Life Sciences/Healthcare Providers & Systems/Ambulatory & Outpatient Care Centers
SECONDARYHLAFAJAA
Obstetrics & Gynecology (OB/GYN) Clinics
Healthcare & Life Sciences/Healthcare Providers & Systems/Women’s & Children’s Health Providers
SECONDARYHLAKAJAF
Minimally Invasive Gynecologic Surgery (Laparoscopy/Hysteroscopy)
NAICS code1 code
  • Freestanding Ambulatory Surgical and Emergency Centers621493
SIC code1 code
  • Services-Specialty Outpatient Facilities, Nec8093
Product category
Interventional Radiology
Social media profiles3 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Processor IP Licensing
TypeLicensing Royalties
Description

MIPS licenses its RISC-V processor IP cores to semiconductor companies and system-on-chip designers. Customers integrate MIPS IP into their own chip designs, paying licensing fees and royalties.

eetimes.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Others, Technology or R&D
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

MIPS (Minimally Invasive Procedure Specialists) is an interventional radiology clinic in Highlands Ranch, Colorado that provides minimally invasive, image-guided treatments for chronic vascular and pelvic conditions including pelvic congestion syndrome, uterine fibroids, varicocele, varicose veins, spider veins, and deep vein thrombosis (DVT). The practice operates a state-of-the-art outpatient interventional suite and has treated patients from all 50 U.S. states and 8 countries.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • EyeQ6 processor powering 75% of ADAS market across 1,200 vehicle models from 50 global OEMs
Product overview1 text field

MIPS, a GlobalFoundries company acquired in July 2024, offers a portfolio of RISC-V processor IP and platforms for physical AI applications. The company has completed its strategic pivot from legacy MIPS instruction set architecture to entirely RISC-V-based eighth-generation products. Core offerings include the S8200 RISC-V NPU for neural processing, P8700 multi-core cluster architecture, and I8500 data movement processor. These are complemented by platforms including the MIPS Atlas Explorer simulation environment, safety-certified microcontroller solutions via the Safety SDK, and robotics reference platforms. The products target automotive (including ADAS), robotics, industrial, and communications infrastructure markets, with key customers including Mobileye and ForwardEdge ASIC.

Product and service7 records
1Pelvic Pain Treatment (Pelvic Congestion Syndrome)
CategoryInterventional Radiology Service
Description

Image-guided, minimally invasive treatment for women with chronic pelvic pain caused by venous insufficiency (pelvic congestion syndrome). Targets often undiagnosed venous causes of pelvic pain and offers treatments less invasive than traditional surgeries.

2Uterine Fibroid Embolization
CategoryInterventional Radiology Service
Description

Minimally invasive, image-guided procedure to treat uterine fibroids by blocking blood flow to fibroid tissue. Performed by interventional radiologists as an alternative to open surgery.

3Varicocele Embolization
CategoryInterventional Radiology Service
Description

Image-guided embolization procedure to treat varicocele (enlarged veins in the scrotum), performed as a minimally invasive alternative to surgical ligation.

4Varicose Vein Treatment
CategoryInterventional Radiology Service
Description

Minimally invasive, image-guided treatment of varicose veins performed by vascular specialists in an outpatient setting.

5Spider Vein Treatment
CategoryInterventional Radiology Service
Description

Treatment for spider veins (a subset of varicose veins) offered as part of the practice's vein care services.

6DVT (Blood Clots) Treatment
CategoryInterventional Radiology Service
Description

Minimally invasive, image-guided treatment for deep vein thrombosis (DVT), including blood clot removal and venous stent placement.

7Telehealth Services
CategoryTelehealth / Patient Services
Description

Remote consultation services enabling patients to access MIPS specialists without traveling to the Highlands Ranch clinic; supports initial consultations and follow-up visits.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2026-04-23
Description

Strategic collaboration to accelerate development of next-generation SoC platforms for physical AI applications. MIPS integrates Arteris' FlexGen Smart Network-on-Chip IP and Magillem SoC Integration Automation Software into its RISC-V processor-based platforms. The partnership addresses key industry challenges including data movement bottlenecks, physical design complexity, and time-to-market pressures for AI-enabled devices targeting automotive, robotics, and embedded computing markets. This partnership builds on collaboration centered on high-performance RISC-V SoCs that began in 2024.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-03-16
Description

Partnership to develop Safety Software Development Kit (Safety SDK) for RISC-V microcontrollers, combining MIPS' M8500 processor architecture with Green Hills' certified development tools and RTOS. The jointly developed toolkit is designed to help manufacturers achieve highest functional safety certifications including ASIL-D for automotive systems and SIL 3/4 for industrial applications. Targeting markets including electric vehicle control, power conversion, motor control, and industrial robotics. Companies are gathering requirements from early access customers.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-03-13
Description

Collaboration to create a new robotics control reference platform for physical AI systems, combining MIPS' RISC-V-based processors with Inova's high-speed data communication technology. The platform is designed as a custom SoC solution supporting the full sense-think-act-communicate chain for advanced robotic systems. Manufactured using GlobalFoundries' FDX process platform. Companies showcased the platform at Embedded World 2026 in Nuremberg, Germany. Early access provided through MIPS Atlas Explorer simulation environment.

Strategic tierFlagshipTypeOthersAnnounced on2026-01-14
Description

MIPS is a subsidiary of GlobalFoundries, acquired in July 2024. GlobalFoundries acquired Synopsys' ARC Processor IP Solutions business to integrate with MIPS, creating a vertically integrated physical AI platform offering both manufacturing and IP licensing through mature technology nodes.

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Major academic vascular and interventional medicine program. Represents the broad incumbent alternative where complex venous and vascular cases are typically referred for hospital-based care.

TypeDirect peer
Description

Outpatient clinic chain specializing in the treatment of venous insufficiency and varicose veins. Competes with MIPS for vein-treatment patients across multiple states under a similar office-based procedural model.

TypeDirect peer
Description

Interventional radiology practice focused on venous disease and minimally invasive vascular procedures. Most directly comparable peer — Dr. Spencer previously served as Medical Director here, and the model (outpatient IR destination clinic) closely mirrors MIPS Center.

TypeDirect peer
Description

Largest U.S. network dedicated to the treatment of venous insufficiency, with 100+ locations. Closest scaled analog offering outpatient vein treatment in a multi-site clinic model, competing for similar patient demographics and procedure mix.

TypeDirect peer
Description

Specialty clinic network dedicated to non-surgical fibroid treatment including uterine fibroid embolization. Directly comparable specialty outpatient procedural model targeting a major MIPS service line.

TypeOthers
Description

Professional medical society for interventional radiologists. Relevant as the industry body that shapes clinical standards, training pipelines, and reimbursement advocacy affecting specialty IR practices like MIPS Center.

TypeDirect peer
Description

Specialty vein clinic chain (formerly Vein Clinics of America) offering outpatient treatment of venous disease. Comparable outpatient procedural model and patient profile to MIPS Center's vein practice.

TypeDirect peer
Description

Independent vascular specialty practice offering outpatient treatment for varicose veins, pelvic congestion, and venous disease. Closely comparable single-specialty procedural model with similar referral-driven patient acquisition.

TypeBroad incumbent
Description

Destination academic vascular program providing the full spectrum of vascular and interventional radiology care. Sets the clinical benchmark MIPS competes against for complex patient referrals.

10Advanced Interventional Radiology Consultants
TypeEmerging player
Description

Independent IR practices offering outpatient embolization and vascular procedures. Comparable niche specialty procedural model, though typically with broader procedure mix than MIPS's venous focus.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI capability2 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

MIPS

Interventional Radiologymipscenter.com

MIPS, a GlobalFoundries subsidiary, licenses RISC-V processor IP cores and NPUs for physical AI applications in automotive ADAS, robotics, and embedded edge computing. Major design wins include Mobileye's EyeQ6 powering 75% of the ADAS market and ForwardEdge ASIC for defense.

What MIPS does

MIPS is a semiconductor intellectual property (IP) company specializing in RISC-V processor architectures for physical AI applications at the autonomous edge. The company was acquired by GlobalFoundries (NASDAQ:GFS) in July 2024 and operates as a wholly-owned subsidiary, positioned within GlobalFoundries' vertically integrated physical AI platform that pairs processor IP with mature-node manufacturing. MIPS has completed a strategic pivot from its legacy MIPS instruction set architecture to RISC-V; its eighth-generation products are entirely RISC-V-based and focused on physical AI workloads in autonomous vehicles, robotics, and embedded edge computing. GlobalFoundries has further announced (January 2026) its acquisition of Synopsys' ARC Processor IP Solutions business to combine with MIPS, consolidating two established RISC architecture lineages under one parent.

MIPS's product portfolio includes the S8200 RISC-V neural processing unit (NPU) for AI inference at the edge, the P8700 six-core cluster scalable up to 64-way replication (768 threads) for high-performance processing, the I8500 multithreaded data movement processor, and the M8500 processor architecture for safety-certified microcontrollers. The company offers reference platforms including the MIPS Atlas Explorer simulation environment, a robotics control reference platform co-developed with Inova Semiconductors, and a Safety SDK with Green Hills Software targeting ASIL-D and SIL 3/4 certifications. Named design wins include Mobileye's EyeQ6 processor — powering 75% of the ADAS market across 1,200 vehicle models from 50 global OEMs — and ForwardEdge ASIC, a Lockheed Martin subsidiary, for mission-critical aerospace and defense applications.

MIPS operates as an IP licensing business, generating revenue through licensing fees and royalties paid by semiconductor companies and SoC designers who integrate MIPS RISC-V cores and NPUs into their own chip designs. Pricing is quote-based and negotiated per customer per project; no public pricing or standalone MIPS revenue is disclosed. Distribution is direct to enterprise customers, with go-to-market executed through industry events (RISC-V Summit, Chiplet Summit, Embedded World, GlobalFoundries Technology Summits), reference platforms co-developed with ecosystem partners (Arteris, Inova, Green Hills), and GlobalFoundries' manufacturing customer network. Note: a data conflict exists in the firmographics, which describe MIPS as a medical practice (Minimally Invasive Procedure Specialists in Highlands Ranch, CO) sharing the same name; this analysis is based on the predominant body of evidence describing the semiconductor IP company.

MIPS firmographics

Firmographics
Name
MIPS
Legal name
MIPS
Website
https://mipscenter.com
Company type
Private
Operating status
Acquired
Headcount range
11–50 employees
Short description
MIPS, a GlobalFoundries subsidiary, licenses RISC-V processor IP cores and NPUs for physical AI applications in automotive ADAS, robotics, and embedded edge computing. Major design wins include Mobileye's EyeQ6 powering 75% of the ADAS market and ForwardEdge ASIC for defense.
Ownership category
akta.pro rank

MIPS industry classification

Industry
Product category
Interventional Radiology
NAICS
Freestanding Ambulatory Surgical and Emergency Centers (621493)
SIC
Services-Specialty Outpatient Facilities, Nec (8093)
akta.pro industry
PRIMARYHLAFABAK
Ambulatory Cardiology Diagnostic & Procedure Centers (Non-hospital-based)
Healthcare & Life Sciences/Healthcare Providers & Systems/Ambulatory & Outpatient Care Centers
SECONDARYHLAFAJAA
Obstetrics & Gynecology (OB/GYN) Clinics
Healthcare & Life Sciences/Healthcare Providers & Systems/Women’s & Children’s Health Providers
SECONDARYHLAKAJAF
Minimally Invasive Gynecologic Surgery (Laparoscopy/Hysteroscopy)

Keywords

  • Interventional radiology
  • Vascular treatments
  • Pelvic pain treatment
  • Uterine fibroid embolization
  • Minimally invasive procedures

Where MIPS is headquartered

Location

Headquarters

HQ city
Highlands Ranch
HQ country
United States
HQ region
North America

Markets served

MIPS business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Others, Technology or R&D

Revenue model

  1. Processor IP Licensing: MIPS licenses its RISC-V processor IP cores to semiconductor companies and system-on-chip designers. Customers integrate MIPS IP into their own chip designs, paying licensing fees and royalties.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

MIPS product offering

Product offering

Core offering

MIPS (Minimally Invasive Procedure Specialists) is an interventional radiology clinic in Highlands Ranch, Colorado that provides minimally invasive, image-guided treatments for chronic vascular and pelvic conditions including pelvic congestion syndrome, uterine fibroids, varicocele, varicose veins, spider veins, and deep vein thrombosis (DVT). The practice operates a state-of-the-art outpatient interventional suite and has treated patients from all 50 U.S. states and 8 countries.

Product overview

MIPS, a GlobalFoundries company acquired in July 2024, offers a portfolio of RISC-V processor IP and platforms for physical AI applications. The company has completed its strategic pivot from legacy MIPS instruction set architecture to entirely RISC-V-based eighth-generation products. Core offerings include the S8200 RISC-V NPU for neural processing, P8700 multi-core cluster architecture, and I8500 data movement processor. These are complemented by platforms including the MIPS Atlas Explorer simulation environment, safety-certified microcontroller solutions via the Safety SDK, and robotics reference platforms. The products target automotive (including ADAS), robotics, industrial, and communications infrastructure markets, with key customers including Mobileye and ForwardEdge ASIC.

Differentiator

Problem solved

Functional benefit

Products and services

  • Pelvic Pain Treatment (Pelvic Congestion Syndrome) Image-guided, minimally invasive treatment for women with chronic pelvic pain caused by venous insufficiency (pelvic congestion syndrome). Targets often undiagnosed venous causes of pelvic pain and offers treatments less invasive than traditional surgeries.
  • Uterine Fibroid Embolization Minimally invasive, image-guided procedure to treat uterine fibroids by blocking blood flow to fibroid tissue. Performed by interventional radiologists as an alternative to open surgery.
  • Varicocele Embolization Image-guided embolization procedure to treat varicocele (enlarged veins in the scrotum), performed as a minimally invasive alternative to surgical ligation.
  • Varicose Vein Treatment Minimally invasive, image-guided treatment of varicose veins performed by vascular specialists in an outpatient setting.
  • Spider Vein Treatment Treatment for spider veins (a subset of varicose veins) offered as part of the practice's vein care services.
  • DVT (Blood Clots) Treatment Minimally invasive, image-guided treatment for deep vein thrombosis (DVT), including blood clot removal and venous stent placement.
  • Telehealth Services Remote consultation services enabling patients to access MIPS specialists without traveling to the Highlands Ranch clinic; supports initial consultations and follow-up visits.

Quantifiable outcome

  • EyeQ6 processor powering 75% of ADAS market across 1,200 vehicle models from 50 global OEMs

Companies that use MIPS

Customer profile

Named customers2 records

Segments4 records

Ideal customer profiles3 records

MIPS technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature6 records

MIPS partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered core and flagship.

  • Arteris Inc.coreTechnology or Integration · 23 April 2026Strategic collaboration to accelerate development of next-generation SoC platforms for physical AI applications. MIPS integrates Arteris' FlexGen Smart Network-on-Chip IP and Magillem SoC Integration Automation Software into its RISC-V processor-based platforms. The partnership addresses key industry challenges including data movement bottlenecks, physical design complexity, and time-to-market pressures for AI-enabled devices targeting automotive, robotics, and embedded computing markets. This partnership builds on collaboration centered on high-performance RISC-V SoCs that began in 2024.
  • Green Hills SoftwarecoreStrategic or Co-development Partner · 16 March 2026Partnership to develop Safety Software Development Kit (Safety SDK) for RISC-V microcontrollers, combining MIPS' M8500 processor architecture with Green Hills' certified development tools and RTOS. The jointly developed toolkit is designed to help manufacturers achieve highest functional safety certifications including ASIL-D for automotive systems and SIL 3/4 for industrial applications. Targeting markets including electric vehicle control, power conversion, motor control, and industrial robotics. Companies are gathering requirements from early access customers.
  • Inova SemiconductorscoreStrategic or Co-development Partner · 13 March 2026Collaboration to create a new robotics control reference platform for physical AI systems, combining MIPS' RISC-V-based processors with Inova's high-speed data communication technology. The platform is designed as a custom SoC solution supporting the full sense-think-act-communicate chain for advanced robotic systems. Manufactured using GlobalFoundries' FDX process platform. Companies showcased the platform at Embedded World 2026 in Nuremberg, Germany. Early access provided through MIPS Atlas Explorer simulation environment.
  • GlobalFoundriesflagshipOthers · 14 January 2026MIPS is a subsidiary of GlobalFoundries, acquired in July 2024. GlobalFoundries acquired Synopsys' ARC Processor IP Solutions business to integrate with MIPS, creating a vertically integrated physical AI platform offering both manufacturing and IP licensing through mature technology nodes.

Scale indicators4 records

Recent moves8 records

Expansion highlights6 records

MIPS competitors and assessment

Company assessment

Broad incumbents

  • Cleveland Clinic Heart, Vascular & Thoracic Institute: Major academic vascular and interventional medicine program. Represents the broad incumbent alternative where complex venous and vascular cases are typically referred for hospital-based care.
  • Mayo Clinic Vascular Center: Destination academic vascular program providing the full spectrum of vascular and interventional radiology care. Sets the clinical benchmark MIPS competes against for complex patient referrals.

Direct peers

  • USA Vein Clinics: Outpatient clinic chain specializing in the treatment of venous insufficiency and varicose veins. Competes with MIPS for vein-treatment patients across multiple states under a similar office-based procedural model.
  • RIA Endovascular Clinic: Interventional radiology practice focused on venous disease and minimally invasive vascular procedures. Most directly comparable peer — Dr. Spencer previously served as Medical Director here, and the model (outpatient IR destination clinic) closely mirrors MIPS Center.
  • Center for Vein Restoration: Largest U.S. network dedicated to the treatment of venous insufficiency, with 100+ locations. Closest scaled analog offering outpatient vein treatment in a multi-site clinic model, competing for similar patient demographics and procedure mix.
  • Fibroid Centers: Specialty clinic network dedicated to non-surgical fibroid treatment including uterine fibroid embolization. Directly comparable specialty outpatient procedural model targeting a major MIPS service line.
  • Inovia Vein Specialty Centers: Specialty vein clinic chain (formerly Vein Clinics of America) offering outpatient treatment of venous disease. Comparable outpatient procedural model and patient profile to MIPS Center's vein practice.
  • Total Vein & Vascular: Independent vascular specialty practice offering outpatient treatment for varicose veins, pelvic congestion, and venous disease. Closely comparable single-specialty procedural model with similar referral-driven patient acquisition.

Others

  • Society of Interventional Radiology: Professional medical society for interventional radiologists. Relevant as the industry body that shapes clinical standards, training pipelines, and reimbursement advocacy affecting specialty IR practices like MIPS Center.

Emerging players

  • Advanced Interventional Radiology Consultants: Independent IR practices offering outpatient embolization and vascular procedures. Comparable niche specialty procedural model, though typically with broader procedure mix than MIPS's venous focus.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

MIPS social profiles

Digital presence

MIPS financial estimates

Financial estimate

Revenue estimate

Valuation estimate

MIPS leadership team

Management profile

Number of profiles

Profiles4 records

MIPS funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

MIPS M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MIPS

What does MIPS do?

MIPS (Minimally Invasive Procedure Specialists) is an interventional radiology clinic in Highlands Ranch, Colorado that provides minimally invasive, image-guided treatments for chronic vascular and pelvic conditions including pelvic congestion syndrome, uterine fibroids, varicocele, varicose veins, spider veins, and deep vein thrombosis (DVT). The practice operates a state-of-the-art outpatient interventional suite and has treated patients from all 50 U.S. states and 8 countries.

Is MIPS a public or private company?

MIPS is a private company. It is classified as founder individual operated bootstrapped and is currently acquired.

When was MIPS founded?

MIPS was founded in -1. It employs 11 to 50 people.

Where is MIPS based?

MIPS is headquartered in Highlands Ranch, United States, in the North America region.

How does MIPS make money?

One revenue line is on record: processor IP Licensing.

Who are MIPS's main competitors?

Broad incumbents on record are Cleveland Clinic Heart, Vascular & Thoracic Institute and Mayo Clinic Vascular Center. Direct peers are USA Vein Clinics, RIA Endovascular Clinic, Center for Vein Restoration, Fibroid Centers, Inovia Vein Specialty Centers and Total Vein & Vascular. Society of Interventional Radiology is listed as an others. Advanced Interventional Radiology Consultants is listed as an emerging player.

Does MIPS have an API?

No public API is recorded for MIPS.

What industry is MIPS in?

MIPS's product category is Interventional Radiology. Its primary akta.pro industry code is HLAFABAK, Ambulatory Cardiology Diagnostic & Procedure Centers (Non-hospital-based), with a secondary code of HLAFAJAA, Obstetrics & Gynecology (OB/GYN) Clinics. Its NAICS code is 621493 and its SIC code is 8093.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
NewswireCyient Semiconductors Announces Strategic Financing with Edelweiss at ~ USD 500 Mn. Equity ValuationCyient Semiconductors announced a strategic financing with Edelweiss at a post-money valuation of ~USD 500 million, including a USD 10 million equity investment and USD 20 million in structured debt. The funds will support R&D, validation infrastructure, and working capital for its power semiconductor and custom silicon business.MarketBeat3 Under-The-Radar Small Caps Making New All-Time HighsThree small-cap stocks—AXT, NWPX, and Ateris—hit new all-time highs. AXT's InP sales drove a 600% YTD surge, NWPX reported record quarterly revenue, and Ateris posted 92% gross margins. Valuations and technical signals suggest short-term pullback risks.Simply Wall StArteris Inc. – Collaboration with MIPS to Accelerate Physical AI SoC PlatformsArteris Inc. announced a strategic collaboration with MIPS, a subsidiary of GlobalFoundries, to accelerate the development of next-generation system-on-chip (SoC) platforms for physical AI applications. Under the agreement, MIPS will integrate Arteris' FlexGen Smart Network-on-Chip IP and Magillem SoC Integration Automation Software into its RISC-V processor-based platforms, targeting automotive, robotics, and embedded computing markets. The partnership addresses key industry challenges including data movement bottlenecks, physical design complexity, and time-to-market pressures for AI-enabled devices.Stock TitanArteris, MIPS partner on physical AI chip designArteris, Inc. announced a collaboration with MIPS, a GlobalFoundries company, to accelerate development of physical AI computing platforms using Arteris FlexGen smart NoC IP and Magillem SoC integration automation software. MIPS will integrate Arteris system IP into its platform offerings to help customers develop optimized SoCs built on MIPS RISC-V processors targeting automotive, robotics, and embedded computing markets. This partnership builds on a collaboration centered on high-performance RISC-V SoCs that began in 2024.New ElectronicsNew Safety SDK for RISC‑V microcontrollers launchedMIPS, now part of GlobalFoundries, has partnered with Green Hills Software to develop a Safety Software Development Kit (Safety SDK) for RISC-V microcontrollers, combining MIPS' M8500 processor architecture with Green Hills' certified development tools and RTOS. The jointly developed toolkit is designed to help manufacturers achieve the highest functional safety certifications, including ASIL-D for automotive systems and SIL 3/4 for industrial applications, targeting markets such as electric vehicle control, power conversion, motor control, and industrial robotics. The companies are currently gathering requirements from early access customers and plan to provide evaluation platforms, motor control demonstrations, and development tools to qualified customers as the programme progresses.Robotics & Automation NewsMIPS and Inova partner to create new robotics reference platform for physical AI systemsMIPS has partnered with German semiconductor company Inova Semiconductors to create a new robotics control reference platform for physical AI systems, combining MIPS' RISC-V-based processors with Inova's high-speed data communication technology. The platform, designed as a custom system-on-chip solution supporting the full sense-think-act-communicate chain for advanced robotic systems, will be manufactured using GlobalFoundries' FDX process platform. The companies showcased the platform at Embedded World 2026 in Nuremberg, Germany, and are providing early access through the MIPS Atlas Explorer simulation environment to accelerate robotics development and reduce time to market.Iconnect007MIPS, INOVA Bring Physical AI to Robotic Hands with New Reference PlatformMIPS and Inova Semiconductors GmbH announced a collaboration to deliver a robotics control reference platform for humanoids and physical AI edge platforms, built on GlobalFoundries technology. The platform aims to simplify robot design, reduce costs, and accelerate market readiness by integrating high-speed communication, secure AI workloads, and real-time control features.New ElectronicsReference platform brings ‘Physical AI’ to roboticsMIPS, now part of GlobalFoundries, announced a collaboration with Inova Semiconductors to develop a robotics control reference platform for humanoids and physical AI edge systems. The platform aims to reduce costs, simplify design, and accelerate development for robotic applications using high-performance, energy-efficient technologies.EetimesMIPS, GlobalFoundries Bet on Physical AIMIPS has completed a strategic pivot from its legacy MIPS instruction set architecture to RISC-V, with its eighth-generation products now entirely RISC-V-based and focused on physical AI applications in autonomous vehicles. The company, acquired by GlobalFoundries in July 2024, highlighted its S8200 RISC-V NPUs and partnerships with key customers including Mobileye, whose EyeQ6 processor powers 75% of the ADAS market across 1,200 vehicle models from 50 global OEMs. GlobalFoundries is positioning itself as a vertically integrated physical AI platform following its acquisitions of MIPS and Synopsys' ARC processor IP business, offering both manufacturing and IP licensing through mature technology nodes.